Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov muag khoom ntawm cas 2306406-51-7 oximbomotide hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 2306406-51-7 oximbomotide los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| Khoom npe | CAS: 2306406-51-7: Oximbomotide |
| Ib ntus | Leu-Met-Asp-Leu-Ser-Thr-Thr-Glu-Val |
| Peb tsab ntawv ib ntus | H-Leu-Met-Asp-Leu-Ser-Thr-Thr-Glu-Val-OH |
| Peptide purity (HPLC, %) | 95%/98%/99% |
| Cov mis mos molecular | C₄₂H₇₃N₉O₁₇S |
| Molecular Luj (Da) | 1008.14 |
Product Basic Information Table
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Puv Amino Acid Sequence | Molecular Formula | Exact Mass (Da) | Qhov nruab nrab MW (Da) | N-Terminal Hloov kho | C-Terminal Hloov kho | Qhov ntev (aa) |
| Oximbomotide | Oximbomotide; Adrenal cancer antigen peptide; CAS Nr .: 2306406-51-7 | Tumor antigen peptide, Kev txhaj tshuaj tiv thaiv kab mob, CTL epitope peptide, qog tshuaj tiv thaiv kab mob, kev tshawb nrhiav qog nqaij hlav qog noj ntshav, qog noj ntshav | Leucine-Methionine-Aspartic acid-Leucine-Serine-Threonine-Threonine-Glutamic acid-Valine | C₄₂H₇₃N₉O₁₇S | 1007.49 | 1008.14 | Dawb amine, unmodified | Dawb carboxyl, unmodified | 9 |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia Cov Cai | Luv -Lub Sijhawm Cia Cov Cai | Kua Stability | Khoom hmoov ruaj khov |
| PEB-OXI001 | hmoov dawb | Khoom hmoov: khaws cia ntawm -20 degree, tiv thaiv los ntawm lub teeb, kaw thiab qhuav, aliquoted; zam rov qab khov-thaw cycles thiab oxidation | Khoom hmoov ruaj khov rau 2 xyoos kaw thiab qhuav ntawm 2-8 degree; npaj cov tshuaj aqueous tshiab ua ntej siv | ruaj khov rau 72 h ntawm 4 degree; ruaj khov rau 6 lub hlis ntawm -80℃hauv aliquots; ruaj khov rau 1 lub hlis ntawm -20℃hauv aliquots. Muaj methionine thioether daim ntawv cog lus, nws yooj yim rau oxidative inactivation. Tsis txhob raug huab cua ntev thiab muaj zog oxidizing tus neeg sawv cev | ruaj khov rau 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-OXI001 | Cov qog nqaij hlav immunogenic CTL epitope peptide rau kev txhaj tshuaj tiv thaiv kab mob thiab kev tsim tshuaj tiv thaiv kab mob qog adrenal | Oximbomotide yog ib qho tshuaj ntsuam qog immunogenic peptide, CTL epitope lees paub los ntawm T hlwb, uas tuaj yeem siv los ua cov tshuaj tiv thaiv qog nqaij hlav hauv cov tshuaj tiv thaiv kab mob. Nws tuaj yeem tau txais thiab ua tiav los ntawm antigen- nthuav tawm cov hlwb (APCs), nthuav tawm ntawm lub xov tooj ntawm tes los ntawm MHC chav kawm I molecules, thiab ua kom muaj kev ua haujlwm ntawm CD8⁺ cytotoxic T cells, ua rau lub hom phiaj tua cov teebmeem tiv thaiv antigen- cov qog hlwb zoo. Cov molecule no tau pib pom nyob rau hauv immunogenic compound tshuaj ntsuam xyuas rau adrenal qog nqaij hlav, thiab ua hauj lwm raws li ib tug cuab tam molecule rau qog cov tshuaj tiv thaiv kab mob, qog immunogenicity validation, T cell activation mechanism kev tshawb fawb, thiab tus kheej qog tshuaj tiv thaiv kab mob. | Kev tshawb fawb qog noj tshuaj tiv thaiv kab mob qog noj ntshav, kev txhim kho qog nqaij hlav, kev tshawb fawb txog qog nqaij hlav qog noj ntshav, kev tshawb fawb T cell activation mechanism, CTL epitope tshuaj ntsuam, Kev tshawb fawb tus kheej immunotherapy | qog- tshwj xeeb antigen epitope; MHC chav kawm I molecule kev nthuav qhia; CTL-kev kho mob qog cell tua txoj kev |
Cim npe nrov: CAS 2306406-51-7 Oximbomotide, Tuam Tshoj CAS 2306406-51-7 Oximbomotide manufacturers, lwm tus neeg, Hoobkas
